Added value of ultra high field MRI for detection of a cause of epilepsy
- Conditions
- EpilepsyFocal drug-resistant epilepsy
- Registration Number
- NL-OMON20236
- Lead Sponsor
- Academic hospital Maastricht (azM), Maastricht, The Netherlands
- Brief Summary
Colon AJ, van Osch MJP, Buijs M, van de Grond J, Boon P, van Buchem MA, Hofman PAM. Detection superiority of 7T MRI protocol in patients with epilepsy and suspected focal cortical dysplasia. Acta Neurol Belg 2016; 116(3):259-269
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Age >=12 years
Drug-resistant focal epilepsy
Exclusion Criteria
Incapacitated to sign informed consent
Not mentally competent individuals (age 16 and above).
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The presence or absence of apparent structural abnormalities on Ultra high field MR brain imaging in patients with focal drug-resistant epilepsy.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does 7T MRI improve detection of focal cortical dysplasia compared to 3T MRI in drug-resistant epilepsy?
What neuroimaging biomarkers correlate with epileptogenic lesion visibility on ultra high field MRI?
Do specific histopathological features of focal epilepsy predict 7T MRI diagnostic superiority?
What are the safety profiles of ultra high field MRI in patients with suspected focal epilepsy?
How might 7T MRI findings influence treatment decisions for focal drug-resistant epilepsy patients?